Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
Hospital Practice (Office Ed.)|September 15, 1993
Aggressive drug therapy for rheumatoid arthritisJ L McGuire, W M RidgwayClinical Immunology and Immunopathology|January 22, 1998
The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetesW M Ridgway, C G FathmanCurrent Opinion in Immunology|January 13, 2000
MHC structure and autoimmune T cell repertoire developmentW M Ridgway, C G FathmanBulletin on the Rheumatic Diseases|January 1, 1990
The endocrine system and connective tissue disordersJ L McGuireJournal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
Increased entry into the IFN-gamma effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic backgroundS Koarada, Y Wu, W M RidgwayCurrent Opinion in Immunology|December 1, 1994
Regulation of autoimmune responseW M Ridgway, H L Weiner, C G FathmanRheumatic Diseases Clinics of North America|August 1, 1996
Overuse syndromes in adult athletesN N Barry, J L McGuireRheumatic Diseases Clinics of North America|August 1, 1996
Acute injuries and specific problems in adult athletesN N Barry, J L McGuireCleveland Clinic Journal of Medicine|July 1, 1994
Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases?R F Van Vollenhoven, J L McGuireAnnales De Medecine Interne|January 1, 1996
Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosusR F Van Vollenhoven, J L McGuirePageof 9